Pregnancy: Leukaemia:Written question - 32067

(East Yorkshire)

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 March 2020
Department of Health and Social Care
Pregnancy: Leukaemia
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of pre-natal testing for HTLV-1; and if he will make a statement.
Answered by: Jo Churchill
Answered on: 24 March 2020

The United Kingdom National Screening Committee (UK NSC) advises Ministers and the National Health Service in the four UK countries about all aspects of population screening and supports implementation of screening programmes.

The UK NSC last reviewed the evidence for the introduction of an antenatal screening programme for Human T-cell Lymphotropic Virus (HTLV) infection in pregnancy in the UK in 2017 and concluded that the evidence did not support the introduction of screening. The UK NSC’s assessment is published and available at the following link:

Share this page